
Pfizer’s heart pill Inspra has gained a new licence in the UK to reduce the risk of death in patients …
Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

